NASDAQ · Financial Statements
Verrica Pharmaceuticals Inc. (VRCA) Financial Statements
$4.11
NASDAQ: VRCA
Market Cap $70.60M
Overview Financials Dividend Verrica Pharmaceuticals Inc. most recently reported annual revenue of $36.0M, net profit of $-18.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $12.0M $9.0M $5.0M $8.0M $36.0M Operating Profit $-31.0M $-21.0M $-66.0M $-66.0M $-12.0M Net Profit $-35.0M $-24.0M $-67.0M $-77.0M $-18.0M EPS $-12.97 $-7.17 $-14.78 $-14.78 $-1.68 Op Margin -257.6% -235.8% -1283.3% -871.3% -33.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $80.0M $45.0M $82.0M $54.0M $47.0M Total Liabilities $48.0M $5.0M $62.0M $64.0M $22.0M Cash $16.0M $34.0M $70.0M $46.0M $30.0M Borrowings $43.0M $2.0M $46.0M $46.0M $2.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-28.0M $-19.0M $-39.0M $-61.0M $-18.0M Investing Cash Flow $-2.0M $54.0M $-1.0M $0 $0 Financing Cash Flow $1.0M $0 $0 $0 $0 Net Cash Flow $5.0M $19.0M $35.0M $-23.0M $-16.0M Free Cash Flow $-28.0M $-19.0M $-39.0M $-61.0M $-18.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.07 EV / EBITDA -2.45 FCF Yield -17.74% Quick Ratio 1.33 Interest Coverage -7.54 Return 1Y -28.32% Return 3Y -91.45% Return 5Y -94.44%
Screens featuring this stock